Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do a Duolingo stock analysis & discuss the risks and upside potential of DUOL stock

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
06 Nov 2025, 03:52 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I'm going to do a Duolingo stock analysis & discuss the risks and upside potential of DUOL stock
Source overview

AI-generated source summary

The analyst discusses Duolingo's recent earnings report, noting a 20% drop in after-hours trading. The report highlighted a 36% year-over-year increase in daily active users and a 20% rise in monthly active users, along with a 34% surge in paid subscribers. Subscriber penetration increased by 0.5%. Total revenue trend shows growth each quarter; Q4 revenue is guided to grow 1% quarter-over-quarter. Quarter-over-quarter growth of monthly and daily active users has declined, suggesting slower growth. Because guidance is now 1% quarter on quarter for the new quarter, the company may hit a growth wall. Using a conservative valuation model, he estimates upside to $428.09 based on 30% growth for 2026, scaling back to 15% by 2030 and a PE ratio of 25. He places a higher emphasis on growth trend consistency rather than bottom fishing.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
355
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail